Institutional Ownership Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY). We have compiled data on the 720 institutions that hold shares in the stock, with a total of 111 Million shares, which have been reported (via 13F filing form) to have a value of $35.9 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Steel Peak Wealth Management LLC
|
Apr 30, 2025 Q1 2025 |
2,727
shares
|
$885,429
0.03% of portfolio
|
Q1 2025
Reduced 21.64%
|
|
|
Buckingham Strategic Partners
Saint Louis, MO |
May 15, 2025 Q1 2025 |
2,724
shares
|
$884,455
0.01% of portfolio
|
Q1 2025
Added 216.01%
|
|
|
Vident Advisory, LLC
Alpharetta, GA |
May 15, 2025 Q1 2025 |
2,667
shares
|
$865,948
0.01% of portfolio
|
Q1 2025
Added 100.98%
|
|
|
Aton Ra Partners
Geneva, V8 |
Feb 05, 2024 Q4 2023 |
2,662
shares
|
$864,324
1.02% of portfolio
|
Q4 2023
Reduced 9.3%
|
|
|
Western Financial Corporation
|
Nov 03, 2022 Q3 2022 |
2,591
shares
|
$841,271
0.36% of portfolio
|
Q3 2022
New holding
|
|
|
Pallas Capital Advisors LLC
Braintree, MA |
Jul 09, 2025 Q2 2025 |
2,570
shares
|
$834,453
0.03% of portfolio
|
Q2 2025
Reduced 61.27%
|
|
|
Degroof Petercam Asset Management
Brussels, C9 |
May 13, 2024 Q1 2024 |
2,520
shares
|
$818,218
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Brinker Capital Investments, LLC
|
Feb 06, 2023 Q4 2022 |
2,512
shares
|
$815,621
0.01% of portfolio
|
Q4 2022
Reduced 5.31%
|
|
|
Uni Super Management Pty LTD
Melbourne, Victoria, C3 |
May 14, 2025 Q1 2025 |
2,500
shares
|
$811,725
0.01% of portfolio
|
Q4 2024
Reduced 16.67%
|
|
|
Vestcor Inc
Fredericton, A3 |
May 08, 2025 Q1 2025 |
2,461
shares
|
$799,062
0.02% of portfolio
|
Q1 2025
Added 0.24%
|
|
|
Aster Capital Management (Difc) LTD
Dubai, C0 |
May 15, 2025 Q1 2025 |
2,451
shares
|
$795,815
0.11% of portfolio
|
Q1 2025
New holding
|
|
|
Wolverine Trading, LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
2,438
shares
|
$791,594
0.0% of portfolio
|
Q1 2025
Reduced 66.71%
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
2,370
shares
|
$769,515
0.0% of portfolio
|
Q1 2025
Reduced 88.22%
|
|
|
Entry Point Capital, LLC
New York, NY |
May 14, 2025 Q1 2025 |
2,364
shares
|
$767,567
0.31% of portfolio
|
Q1 2025
Reduced 7.0%
|
|
|
Kovitz Investment Group Partners, LLC
|
May 19, 2025 Q1 2025 |
2,349
shares
|
$762,696
0.0% of portfolio
|
Q1 2025
Reduced 10.79%
|
|
|
Peak6 LLC
Chicago, IL |
May 14, 2025 Q1 2025 |
2,295
shares
|
$745,163
0.0% of portfolio
|
Q1 2025
Reduced 78.56%
|
|
|
Nixon Peabody Trust CO
Boston, MA |
Apr 10, 2025 Q1 2025 |
2,277
shares
|
$739,319
0.05% of portfolio
|
Q1 2025
Reduced 0.7%
|
|
|
Ci Investments Inc.
Toronto, A6 |
May 13, 2025 Q1 2025 |
2,221
shares
|
$721,136
0.0% of portfolio
|
Q1 2025
Reduced 36.25%
|
|
|
New York Life Investment Management LLC
New York, NY |
May 08, 2025 Q1 2025 |
2,214
shares
|
$718,863
0.01% of portfolio
|
Q1 2025
Reduced 7.13%
|
|
|
Bannerman Wealth Management Group, LLC
Lewisville, TX |
Jul 15, 2025 Q2 2025 |
2,164
shares
|
$702,629
0.54% of portfolio
|
Q2 2025
Reduced 20.7%
|
|
|
Monograph Wealth Advisors, LLC
|
May 14, 2025 Q1 2025 |
2,126
shares
|
$690,290
0.08% of portfolio
|
Q1 2025
Reduced 0.56%
|
|
|
Corient Capital Partners, LLC
Newport Beach, CA |
Nov 14, 2022 Q3 2022 |
2,121
shares
|
$688,667
0.02% of portfolio
|
Q2 2022
Reduced 6.81%
|
|
|
Park Avenue Securities LLC
|
Jul 14, 2025 Q2 2025 |
2,085
shares
|
$676,978
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Sava Infond D.O.O.
Maribor, 2A |
Apr 23, 2025 Q1 2025 |
2,080
shares
|
$675,355
0.11% of portfolio
|
Q1 2025
Added 20.23%
|
|
|
Prudential PLC
London, England, X0 |
May 13, 2025 Q1 2025 |
2,047
shares
|
$664,640
0.0% of portfolio
|
Q1 2025
Reduced 52.17%
|